← FDA DRUG APPROVALS

FDA ANDA · ANDA213559

TRIAMCINOLONE ACETONIDE

Sponsor: QUAGEN

APPLICATION
ANDA213559
TYPE
ANDA
ORIGINAL APPROVAL
2020-07-01
LATEST ACTION
2020-07-01
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.025% · LOTION · TOPICAL
TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.1% · LOTION · TOPICAL

Approval history

2020-07-01UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →